Women's Health Market by Age Group Type (50 Years and Above, and Others), Application (Contraceptives, Osteoporosis, Menopause, Infertility, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
The global women's health market size reached US$ 39.32 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 51.65 Billion by 2028, exhibiting a growth rate (CAGR) of 4.33% during 2023-2028. The rising incidences of chronic illnesses among women, significant technological advancements, and extensive research and development (R&D) activities represent some of the key factors driving the market.
Women's health refers to the branch of medicine that encompasses various physical, mental, and emotional health concerns that affect a woman's physical and emotional well-being. It includes issues related to reproductive health, menstruation, pregnancy, childbirth, menopause, aging, and concerns related to breast health, sexual health, and mental health. Some of the most common women's health issues include menstrual disorders, such as painful periods, irregular periods, and heavy bleeding, as well as reproductive health concerns, such as infertility, sexually transmitted infections (STIs), and cervical cancer. Women's health helps to enhance overall health in women, reduce the risk of chronic diseases, improve the physical, mental, and emotional health of women, and improve health outcomes.
Women's Health Market Trends:
The rising incidences of chronic illnesses among women across the globe are one of the key factors driving the market growth. In line with this, the increasing demand for women's health products and services that help prevent, diagnose, and treat chronic diseases, such as heart disease, diabetes, osteoporosis, PCOD, and breast cancer, is favoring the market growth. Additionally, rising awareness and education regarding health needs and the available treatment options are acting as another growth-inducing factor. Apart from this, key players are focusing on the introduction of new diagnostic tests that can detect conditions such as breast cancer and cervical cancer at an early stage, improving treatment outcomes and reducing the burden of chronic disease on women, which in turn is providing an impetus to the market growth. Moreover, the launch of digital health tools, such as mobile apps, wearables, and telehealth services that help women track their menstrual cycle, monitor pregnancy, and manage conditions such as diabetes and hypertension, is propelling the market growth. Furthermore, the rising incidences of stress-related osteoarthritis, infertility, and other illnesses are creating a positive outlook for the market. Besides this, the development of new pharmaceuticals and the integration of artificial intelligence (AI) algorithms to analyze mammogram images and detect breast cancer at an early stage is providing a thrust to the market growth. Other factors, including rising expenditure capacities, increasing women working population, extensive research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote women's health, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global women's health market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on age group, application, and distribution channel.
Age Group Type Insights:
50 Years and Above
Postmenopausal Osteoporosis
Endometriosis and Uterine Fibroids
Menopause
Others
The report has provided a detailed breakup and analysis of the women's health market based on the age group. This includes 50 years and above (postmenopausal osteoporosis, endometriosis and uterine fibroids, and menopause), and others. According to the report, 50 years and above represented the largest segment.
Application Insights:
Contraceptives
Osteoporosis
Menopause
Infertility
Others
The report has provided a detailed breakup and analysis of the women's health market based on the application. This includes contraceptives, osteoporosis, menopause, infertility, and others. According to the report, contraceptives represented the largest segment.
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
A detailed breakup and analysis of the women's health market based on the distribution channel has also been provided in the report. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for women's health. Some of the factors driving the North America women's health market included the rising incidences of chronic illnesses among women, significant technological advancements, and increasing expenditure capacities.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global women's health market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AbbVie Inc., Agile Therapeutics Inc., Amgen Inc., Bayer AG, Hoffmann-La Roche AG, Ferring Pharmaceuticals, FUJIFILM Holdings Corporation, Hologic Inc., Lupin Limited, Novo Nordisk A/S, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global women's health market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global women's health market?
What is the impact of each driver, restraint, and opportunity on the global women's health market?
What are the key regional markets?
Which countries represent the most attractive women's health market?
What is the breakup of the market based on the age group?
Which is the most attractive age group in the women's health market?
What is the breakup of the market based on the application?
Which is the most attractive application in the women's health market?
What is the breakup of the market based on the distribution channel?
Which is the most attractive distribution channel in the women's health market?
What is the competitive structure of the global women's health market?
Who are the key players/companies in the global women's health market?
Women's health refers to the branch of medicine that encompasses various physical, mental, and emotional health concerns that affect a woman's physical and emotional well-being. It includes issues related to reproductive health, menstruation, pregnancy, childbirth, menopause, aging, and concerns related to breast health, sexual health, and mental health. Some of the most common women's health issues include menstrual disorders, such as painful periods, irregular periods, and heavy bleeding, as well as reproductive health concerns, such as infertility, sexually transmitted infections (STIs), and cervical cancer. Women's health helps to enhance overall health in women, reduce the risk of chronic diseases, improve the physical, mental, and emotional health of women, and improve health outcomes.
Women's Health Market Trends:
The rising incidences of chronic illnesses among women across the globe are one of the key factors driving the market growth. In line with this, the increasing demand for women's health products and services that help prevent, diagnose, and treat chronic diseases, such as heart disease, diabetes, osteoporosis, PCOD, and breast cancer, is favoring the market growth. Additionally, rising awareness and education regarding health needs and the available treatment options are acting as another growth-inducing factor. Apart from this, key players are focusing on the introduction of new diagnostic tests that can detect conditions such as breast cancer and cervical cancer at an early stage, improving treatment outcomes and reducing the burden of chronic disease on women, which in turn is providing an impetus to the market growth. Moreover, the launch of digital health tools, such as mobile apps, wearables, and telehealth services that help women track their menstrual cycle, monitor pregnancy, and manage conditions such as diabetes and hypertension, is propelling the market growth. Furthermore, the rising incidences of stress-related osteoarthritis, infertility, and other illnesses are creating a positive outlook for the market. Besides this, the development of new pharmaceuticals and the integration of artificial intelligence (AI) algorithms to analyze mammogram images and detect breast cancer at an early stage is providing a thrust to the market growth. Other factors, including rising expenditure capacities, increasing women working population, extensive research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote women's health, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global women's health market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on age group, application, and distribution channel.
Age Group Type Insights:
50 Years and Above
Postmenopausal Osteoporosis
Endometriosis and Uterine Fibroids
Menopause
Others
The report has provided a detailed breakup and analysis of the women's health market based on the age group. This includes 50 years and above (postmenopausal osteoporosis, endometriosis and uterine fibroids, and menopause), and others. According to the report, 50 years and above represented the largest segment.
Application Insights:
Contraceptives
Osteoporosis
Menopause
Infertility
Others
The report has provided a detailed breakup and analysis of the women's health market based on the application. This includes contraceptives, osteoporosis, menopause, infertility, and others. According to the report, contraceptives represented the largest segment.
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
A detailed breakup and analysis of the women's health market based on the distribution channel has also been provided in the report. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for women's health. Some of the factors driving the North America women's health market included the rising incidences of chronic illnesses among women, significant technological advancements, and increasing expenditure capacities.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global women's health market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AbbVie Inc., Agile Therapeutics Inc., Amgen Inc., Bayer AG, Hoffmann-La Roche AG, Ferring Pharmaceuticals, FUJIFILM Holdings Corporation, Hologic Inc., Lupin Limited, Novo Nordisk A/S, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global women's health market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global women's health market?
What is the impact of each driver, restraint, and opportunity on the global women's health market?
What are the key regional markets?
Which countries represent the most attractive women's health market?
What is the breakup of the market based on the age group?
Which is the most attractive age group in the women's health market?
What is the breakup of the market based on the application?
Which is the most attractive application in the women's health market?
What is the breakup of the market based on the distribution channel?
Which is the most attractive distribution channel in the women's health market?
What is the competitive structure of the global women's health market?
Who are the key players/companies in the global women's health market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL WOMEN'S HEALTH MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY AGE GROUP
6.1 50 Years and Above
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Postmenopausal Osteoporosis
6.1.2.2 Endometriosis and Uterine Fibroids
6.1.2.3 Menopause
6.1.3 Market Forecast
6.2 Others
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Contraceptives
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Osteoporosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Menopause
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Infertility
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AbbVie Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Agile Therapeutics Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Amgen Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Bayer AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Ferring Pharmaceuticals
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 FUJIFILM Holdings Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Hologic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Lupin Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Novo Nordisk A/S
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Pfizer Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT AnalysisKindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL WOMEN'S HEALTH MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY AGE GROUP
6.1 50 Years and Above
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Postmenopausal Osteoporosis
6.1.2.2 Endometriosis and Uterine Fibroids
6.1.2.3 Menopause
6.1.3 Market Forecast
6.2 Others
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Contraceptives
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Osteoporosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Menopause
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Infertility
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AbbVie Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Agile Therapeutics Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Amgen Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Bayer AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Ferring Pharmaceuticals
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 FUJIFILM Holdings Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Hologic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Lupin Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Novo Nordisk A/S
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Pfizer Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT AnalysisKindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
LIST OF TABLES
Table 1: Global: Women's Health Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Women's Health Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 3: Global: Women's Health Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Women's Health Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Women's Health Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Women's Health Market: Competitive Structure
Table 7: Global: Women's Health Market: Key Players
Table 1: Global: Women's Health Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Women's Health Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 3: Global: Women's Health Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Women's Health Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Women's Health Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Women's Health Market: Competitive Structure
Table 7: Global: Women's Health Market: Key Players
LIST OF FIGURES
Figure 1: Global: Women's Health Market: Major Drivers and Challenges
Figure 2: Global: Women's Health Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Women's Health Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Women's Health Market: Breakup by Age Group (in %), 2022
Figure 5: Global: Women's Health Market: Breakup by Application (in %), 2022
Figure 6: Global: Women's Health Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Women's Health Market: Breakup by Region (in %), 2022
Figure 8: Global: Women's Health (50 Years and Above) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Women's Health (50 Years and Above) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Women's Health (Other Age Groups) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Women's Health (Other Age Groups) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Women's Health (Contraceptives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Women's Health (Contraceptives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Women's Health (Osteoporosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Women's Health (Osteoporosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Women's Health (Menopause) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Women's Health (Menopause) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Women's Health (Infertility) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Women's Health (Infertility) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Women's Health (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Women's Health (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Women's Health (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Women's Health (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Women's Health (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Women's Health (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Women's Health (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Women's Health (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Women's Health Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Women's Health Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Women's Health Industry: Value Chain Analysis
Figure 79: Global: Women's Health Industry: Porter's Five Forces Analysis
Figure 1: Global: Women's Health Market: Major Drivers and Challenges
Figure 2: Global: Women's Health Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Women's Health Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Women's Health Market: Breakup by Age Group (in %), 2022
Figure 5: Global: Women's Health Market: Breakup by Application (in %), 2022
Figure 6: Global: Women's Health Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Women's Health Market: Breakup by Region (in %), 2022
Figure 8: Global: Women's Health (50 Years and Above) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Women's Health (50 Years and Above) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Women's Health (Other Age Groups) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Women's Health (Other Age Groups) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Women's Health (Contraceptives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Women's Health (Contraceptives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Women's Health (Osteoporosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Women's Health (Osteoporosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Women's Health (Menopause) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Women's Health (Menopause) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Women's Health (Infertility) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Women's Health (Infertility) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Women's Health (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Women's Health (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Women's Health (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Women's Health (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Women's Health (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Women's Health (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Women's Health (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Women's Health (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Women's Health Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Women's Health Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Women's Health Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Women's Health Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Women's Health Industry: Value Chain Analysis
Figure 79: Global: Women's Health Industry: Porter's Five Forces Analysis
